What Jeff Sessions Doesn’t Understand About Medical

New Post Public Reply Private Reply Replies (3) Message Board
wowhappens28
362
What Jeff Sessions Doesn’t Understand About Medical Marijuana

https://www.ecowatch.com/sessions-medical-mar...07998.html

On Jan. 4, Attorney General Jeff Sessions rescinded the Cole memo, a 2013 document that limits federal enforcement of marijuana laws.

This opens the door for a crackdown in the nine states with legal recreational marijuana.

The Cole memo is one of two documents that prevent the U.S. Justice Department from treating marijuana as a Schedule I drug, defined as a substance with no accepted medical treatment and high potential for abuse. The other is the 2014 Rohrabacher–Farr amendment. This legislation bars the Department of Justice from spending any funds to keep states from implementing their own laws about "the use, distribution, possession or cultivation of medical marijuana."

The amendment's language needs to be reinserted into law each year—and it's currently set to expire on Jan. 18. That would leave patients in the 29 states with legal medical marijuana without their treatments and at risk of prosecution.

I have researched a number of drugs of abuse and natural products for safety and effectiveness. Just because a drug has abuse potential doesn't mean it's always bad and just because it's natural doesn't mean it's always safe. While I'm no fan of legalizing recreational marijuana use, I believe there has to be special dispensation for patients with a legitimate medical need.

Medical Marijuana Works

There are approximately 1.2 million users of medical marijuana in these 29 states. Some of the most common ailments include pain or muscle spasms, nausea and vomiting, cancer, PTSD, seizures and glaucoma.

Patients in 29 states can legally use medical marijuana

The body has a system of receptors that can be stimulated by the chemicals in marijuana, called cannabinoids. In animal studies, cannabinoids have been used to treat symptoms like harmful weight loss, vomiting, seizures and fluid pressure in the eyes.
There isn't much human research on medical marijuana, thanks to the product's illegal status and a lack of federal research funding. Large trials are nearly impossible to conduct, since products are often adulterated and the concentrations of cannabinoids vary from plant to plant.

Even so, human trials from around the world and pockets of the U.S. offer modestly strong evidence of marijuana's benefits in a number of disorders, such as intractable nausea and vomiting, chronic pain and severe muscle spasms and epilepsy.

For example, a study published in May looked at the effects of cannabadiol—an active marijuana compound that does not cause euphoric high or hallucination—on children with Dravet syndrome, a rare genetic disorder characterized by frequent, severe drug-resistant seizures. Those who took cannabadiol cut their median number of convulsive seizures per month in half, from 12 to six. These findings may be applicable to other people with hard-to-treat seizures.

I bring up this example because it uses the highest quality study design. Also, seizures are not subjective symptoms like pain or nausea that critics may be skeptical of.

When Patients Become Criminals

In my home state of Connecticut, medical marijuana is legal. Doctors are required to certify that potential medical marijuana users have a disease for which there is adequate medical evidence for marijuana's benefit. The patient then visits a licensed dispensary facility, where a pharmacists helps to select the type of product that would work best.

In such a dispensary, pharmacists know the exact amount of the active chemicals that each product contains. Unlike illegal marijuana, their products aren't contaminated with heavy metals, bacteria, fungi, herbicides or pesticides.

What if patients can no longer access these products? They will either have to go without and lose the benefits of their treatment, leading to moderately intense marijuana withdrawal symptoms, such as insomnia, chills, shakiness and stomach pain.

Or, they might try to switch to the black market, where products may be inconsistent and prosecution is possible. In so doing, they would be supporting organized crime and exposing themselves to additional dangers. I especially worry about children with epilepsy who might have to use illegal marijuana that gives them a high due to the tetrahydrocannabinol (THC) rather than a legal version with little to no THC.

A Balanced Approach

Since 2014, the Rohrabacher-Farr amendment has been routinely included in the appropriations language with support from both parties. But in the past year, things have broken down. So far, the amendment has survived through resolutions to extend government spending, but it's unclear whether it will appear in the new federal budget.

Sessions has already written to members of Congress asking them not to support this amendment, saying it inhibits the department's authority. A new subcommittee at the Department of Justice plans to assess the legalized use of marijuana.

Legal recreational marijuana comes with potential benefits and drawbacks to society, and I'm not sure yet that we know what the impact will be over the long term. But the research on medical marijuana is clear: Marijuana has legitimate medical uses. It should not be a Schedule I drug and should not be denied to patients. There's virtually no upside to banning a potentially effective therapy for patients with diseases like cancer, multiple sclerosis and epilepsy.

Reposted with permission from our media associate The Conversation.

RELATED ARTICLES AROUND THE WEB
Legal Marijuana Is Supported by Every Group in America Except Jeff ... ›
New Analysis Shows Federal Marijuana Legalization Could Raise ... ›
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gateway Unveils All-In-One Award Travel Platform

Updated Category News Views 5

Transforming Loyalty with point.me's Gateway Here's the deal: the loyalty program game just changed. Point.me rolled out this slick beast called Gateway, and it's weaving award travel booking right into your everyday banking apps. That's right, ditch those clunky third-party sites, because now you can browse, compare, transfer, and book your award travel directly from...

Continue Reading
Neutonic Sets Sights on U.S. with Walmart Expansion

Updated Category News Views 8

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Continue Reading
Cannatrol and Veterans Nonprofit Unite for Healing

Updated Category News Views 1

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Continue Reading
Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Updated Category News Views 3

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Continue Reading
Ultrabench Revolutionizes AI Model Comparison Game

Updated Category News Views 3

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Continue Reading
Varda Space's Dual Launch Signals Orbital Ambitions

Updated Category News Views 1

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Continue Reading
October Becomes a Beacon for Grieving Families

Updated Category News Views 1

October: A Month for Heartfelt Observance There's a profound resonance when October rolls around, especially for families who've faced the heartbreak of pregnancy or infant loss. Thanks to Postpartum Support International (PSI), the month serves as more than just a page in a calendar—it's a solidarity rallying cry for awareness and remembrance. The group's commitment to...

Continue Reading
Athlete Threats: Public Info Fuels Security Risks

Updated Category News Views 3

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Continue Reading
Mitsubishi's Q3 Sales: SUVs Up, Mirage Out

Updated Category News Views 0

You ever notice how the market treats innovation and tradition like they’re these ever-spinning plates in a circus act? Take Mitsubishi Motors North America (MMNA). Their third-quarter report's got me both nodding in approval and scratching my head. Sure, they sold 18,543 vehicles—down 5.6% from the previous year. But don’t write 'em off just yet. The slumping...

Continue Reading
New Tools Arm Manufacturers in Additive Arena

Updated Category News Views 2

Diving Headfirst into Additive Manufacturing Standards Additive manufacturing (AM)—it's not just another tech buzzword. It's revolutionizing everything from life-saving medical devices to cutting-edge aerospace components. But as with any game-changing innovation, there's a wild west era before standards reign in the chaos. Enter ANSI and America Makes, offering new...

Continue Reading

Top 5 Most Recently Viewed Articles

Holly Farrell Takes Charge as General Manager at The Oaks Club

Updated Category News Views 142

Welcoming Holly Farrell as the General Manager The Oaks Club has made a significant announcement with the appointment of Holly Farrell as their new General Manager and Chief Operating Officer. This remarkable decision marks an important milestone, as it brings the first female to the top position in the club's 40-year history. Farrell’s leadership is set to bring fresh...

Continue Reading
Transformative Growth in India’s Oncology Market Through AI

Updated Category News Views 207

Transformative Growth in India’s Oncology Market Through AI The oncology market in India is experiencing rapid growth, with an estimated increase of USD 1.49 billion predicted between 2024 and 2028. According to market insights provided by industry experts, the compound annual growth rate (CAGR) is anticipated to be around 17.43%. This surge is primarily driven by the...

Continue Reading
FIGS Unveils its Second Community Hub in Philadelphia

Updated Category News Views 351

FIGS Expands Its Retail Presence on the East Coast FIGS, Inc. (NYSE: FIGS), a prominent name in healthcare apparel, has proudly opened its second Community Hub in Philadelphia. This milestone represents a significant effort to grow its retail presence and better cater to healthcare professionals in the area. A New Shopping Experience for Healthcare Professionals The...

Continue Reading
Ondas Holdings Expands Its Market Reach with S.P.O Acquisition

Updated Category News Views 177

Ondas Holdings Makes Strategic Move With S.P.O Acquisition Ondas Holdings Inc (NASDAQ: ONDS) is gaining attention as its shares experience an upward trend. This movement comes on the heels of the company announcing a significant acquisition: a majority stake in S.P.O Smart Precision Optics. Details of the Acquisition Ondas has entered an agreement to acquire a controlling...

Continue Reading
Texas Instruments Earnings: What Investors Should Expect

Updated Category News Views 51

Overview of Upcoming Earnings for Texas Instruments Texas Instruments (NASDAQ: TXN) is set to reveal its quarterly earnings soon. Investors are keenly observing the company's progress and what information will be shared regarding its financial health and future performance. Industry analysts project an earnings per share (EPS) of $1.37 for this quarter. This figure, if...

Continue Reading